91 related articles for article (PubMed ID: 28425753)
21. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
[TBL] [Abstract][Full Text] [Related]
22. Typing of red cells on microplates by the low-ionic polybrene technique.
Redman M; Malde R; Knight RC
Med Lab Sci; 1986 Oct; 43(4):393-4. PubMed ID: 3657420
[No Abstract] [Full Text] [Related]
23. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
[No Abstract] [Full Text] [Related]
24. Advances in solid phase red cell adherence methods and transfusion serology.
Sinor LT
Beitr Infusionsther; 1990; 26():345-7. PubMed ID: 1703870
[No Abstract] [Full Text] [Related]
25. [Characteristics of anti-Coa antibodies of the Colton blood group system and their significance in hemotherapy].
Kuśnierz G; Bragiel I; Nowakowska E; Cwirko Z
Acta Haematol Pol; 1983; 14(2):117-24. PubMed ID: 6673468
[No Abstract] [Full Text] [Related]
26. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
Thomas L; Tuscany FL; Wilner GD
Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
[TBL] [Abstract][Full Text] [Related]
27. Automation of cross-matching and red cell antibody screening.
Wattar B; Lambermont M; Govaerts A
Vox Sang; 1982; 42(4):169-79. PubMed ID: 7090333
[TBL] [Abstract][Full Text] [Related]
28. Anti-Rga: identifying serologic characteristics.
Strohm PL; Molthan L
Am J Med Technol; 1982 Dec; 48(12):997-1002. PubMed ID: 7165034
[TBL] [Abstract][Full Text] [Related]
29. A new paradigm for pretransfusion testing with the same perennial limitations.
Westhoff CM; Anstee DJ
Transfusion; 2010 Mar; 50(3):520-1. PubMed ID: 20609198
[No Abstract] [Full Text] [Related]
30. Red cell alloimmunisation in oncology patients: A study from eastern India.
Dhar S; Basu S
Transfus Apher Sci; 2015 Jun; 52(3):345-9. PubMed ID: 25818996
[TBL] [Abstract][Full Text] [Related]
31. [Phenomenon of indirect isoserological incompatibility in experimental transfusion research and its clinical significance].
Sumbatov LA; Iunovidova LI
Biull Eksp Biol Med; 1985 Jan; 99(1):15-7. PubMed ID: 3967064
[TBL] [Abstract][Full Text] [Related]
32. [Molecular and genetic bases of the Gerbich blood-group system of human erythrocytes].
Jaśkiewicz E
Postepy Biochem; 1991; 37(2):75-81. PubMed ID: 1819798
[No Abstract] [Full Text] [Related]
33. Patients with anti-Vel--immunohematological characterization and transfusion management.
Lynen R; Simson G; Quentin SH; Schulte B; The LG; Neumeyer H
Beitr Infusionsther; 1990; 26():377-9. PubMed ID: 1703877
[TBL] [Abstract][Full Text] [Related]
34. [A pregnant woman with irregular erythrocyte antibodies for whom no compatible packed red blood cells were available].
Boonstra JG; Overbeeke MA; de Rijke YB; Duvekot JJ
Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2633-6. PubMed ID: 16355577
[TBL] [Abstract][Full Text] [Related]
35. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion.
Liepkalns JS; Cadwell CM; Stowell SR; Hod EA; Spitalnik SL; Zimring JC
Transfusion; 2013 Jun; 53(6):1319-27. PubMed ID: 23033973
[TBL] [Abstract][Full Text] [Related]
36. [The frequency of irregular erythrocyte antibodies (author's transl)].
Maurer C; Büttner J
Dtsch Med Wochenschr; 1975 Jul; 100(30):1567-70, 1573. PubMed ID: 808403
[TBL] [Abstract][Full Text] [Related]
37. [Use of standard erythrocytes and relevant antisera and reagents for rapid selection of blood donors for hematologic patients sensitized to various systems of erythrocyte antigens].
Kiem ChS; Tuen BK; An' ChK; Tananov AT; Piskunova TM
Gematol Transfuziol; 1989 May; 34(5):55-60. PubMed ID: 2744391
[No Abstract] [Full Text] [Related]
38. HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.
Schonewille H; Doxiadis II; Levering WH; Roelen DL; Claas FH; Brand A
Transfusion; 2014 Aug; 54(8):1971-80. PubMed ID: 24654685
[TBL] [Abstract][Full Text] [Related]
39. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
Noumsi GT; Billingsley KL; Moulds JM
Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
[TBL] [Abstract][Full Text] [Related]
40. [Strategies for prevention of adverse transfusion effects. Immediate and delayed transfusion effects: laboratory reference for transfusion reactions].
Kiyokawa H
Rinsho Byori; 1991 Mar; Suppl 88():128-37. PubMed ID: 1856964
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
